Mounjaro In India
- All
- News
- Web Stories
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
www.ndtv.com
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
- Wednesday February 25, 2026
- Health | Written by Shreya Goswami
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
www.ndtv.com
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
- Saturday January 24, 2026
- Health | Written by Debosmita Ghosh
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Mounjaro For Weight Loss Becomes Second-Highest Selling Drug In India In 6 Months
- Wednesday October 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore
-
www.ndtv.com/lifestyle
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Mounjaro Is In India, Ozempic Coming Soon. How Are We Taking Trump's 'Fat Shot' Drugs?
- Wednesday May 14, 2025
- Lifestyle | Written by Dristi Sharma
Mounjaro has arrived in India, and the demand is rising fast. But will it stick? We tried to find out
-
www.ndtv.com/lifestyle
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
- Thursday February 26, 2026
- Health | Written by Shreya Goswami
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
www.ndtv.com
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
- Wednesday February 25, 2026
- Health | Written by Shreya Goswami
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
www.ndtv.com
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
- Saturday January 24, 2026
- Health | Written by Debosmita Ghosh
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
www.ndtv.com
-
Ozempic Injection Price In India: How Affordable Is It For Diabetes And Weight Loss?
- Friday December 12, 2025
- Health | Written by Shreya Goswami
Ozempic, a once-weekly semaglutide injection for type-2 diabetes, has debuted in India with pricing starting at roughly Rs 2,200 per week.
-
www.ndtv.com
-
Ozempic Launched In India: Doctors Welcome New Diabetes Drug, Warn Against Misuse For Weight Loss
- Friday December 12, 2025
- Health | Written by Debosmita Ghosh
Doctors highlight that the drug should be administered along with a healthy diet and regular exercise for management of type 2 diabetes, and not just as cosmetic procedure for weight loss.
-
www.ndtv.com
-
Mounjaro For Weight Loss Becomes Second-Highest Selling Drug In India In 6 Months
- Wednesday October 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
Mounjaro recorded Rs 80 crore in sales in September, trailing only GSK's antibiotic Augmentin, which registered Rs 85 crore
-
www.ndtv.com/lifestyle
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
- Wednesday September 10, 2025
- Health | Written by Shreya Goswami
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
www.ndtv.com
-
Wegovy And Mounjaro For Weight Loss Are In, But India Wants A No-Drug Obesity Fix
- Tuesday July 8, 2025
- Lifestyle | Written by NDTV Lifestyle Desk
A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications
-
www.ndtv.com/lifestyle
-
Mounjaro Is In India, Ozempic Coming Soon. How Are We Taking Trump's 'Fat Shot' Drugs?
- Wednesday May 14, 2025
- Lifestyle | Written by Dristi Sharma
Mounjaro has arrived in India, and the demand is rising fast. But will it stick? We tried to find out
-
www.ndtv.com/lifestyle